NIPT for Down Syndrome in Nepal — Accurate Non-Invasive Prenatal Screening Screening for trisomy 21 from a simple maternal blood sample
Non-invasive prenatal testing screens for Down syndrome (trisomy 21) using cell-free fetal DNA in maternal blood from around 10 weeks of pregnancy. Learn how NIPT works, how accurate it is, and what happens after a high-risk result in Nepal.
Medically Reviewed Content
Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Last medical review: November 8, 2026
Next scheduled review: May 8, 2027
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
Important Information About Prenatal Screening
- NIPT is a screening test, not a diagnostic test — a high-risk result does not confirm Down syndrome and requires amniocentesis or CVS for certainty.
- A low-risk NIPT result does not eliminate all risks — structural abnormalities and other conditions are not detected by this test.
- Diagnostic procedures like amniocentesis carry a small miscarriage risk and should only be considered after thorough counselling.
- All screening decisions are personal — our counselling is non-directive and supports whatever choice you make for your pregnancy.
- Results should always be interpreted alongside ultrasound findings and by a qualified clinician who understands your full medical picture.
NIPT for Down Syndrome in Nepal
- Growing availability — NIPT is now offered by private laboratories in Kathmandu and is increasingly accessible to Nepali families, though it remains a private-pay service rather than part of routine public antenatal care.
- Maternal age context — Nepal's fertility patterns mean many pregnancies occur in younger women, where Down syndrome risk is lower but not zero; NIPT offers reassurance across all ages.
- Diagnostic confirmation is limited — amniocentesis and CVS require specialist centres; most are in Kathmandu, so counselling must include realistic plans for confirmatory testing.
- Cost considerations — NIPT is priced higher than routine antenatal tests, typically in the range of tens of thousands of rupees; transparent quoting and payment planning help families decide.
- Cultural sensitivity — pregnancy and genetic testing carry cultural weight in Nepal; our counselling is respectful, non-directive and conducted in the patient's preferred language where possible.
- Integration with antenatal care — NIPT complements, not replaces, ultrasound scans and standard antenatal checks; it screens chromosomes while ultrasound assesses structure.
What NIPT for Down Syndrome Is and Why It Matters
Non-invasive prenatal testing (NIPT) is a screening blood test offered from about 10 weeks of pregnancy that analyses cell-free DNA — small fragments of placental DNA that circulate in the mother's bloodstream. For Down syndrome, the test measures the proportion of chromosome 21 material. An excess suggests trisomy 21, the chromosomal cause of Down syndrome.
NIPT is a screening test, not a diagnostic test. It is considerably more accurate than older serum screening methods, with detection rates for trisomy 21 commonly reported above 99 percent and false-positive rates below 1 percent in low-risk pregnancies. However, a high-risk result does not confirm Down syndrome — it means diagnostic testing such as amniocentesis or chorionic villus sampling is needed to be certain.
Down syndrome is the most common chromosomal condition screened in pregnancy, and its likelihood increases with maternal age. Every pregnant woman can access NIPT regardless of age, and many choose it for the peace of mind that a simple blood draw provides without any risk to the pregnancy.
This guide explains how the test works, who should consider it, what the results mean, how it compares with other screening options, and how positive results are confirmed — with confidential counselling throughout at Thamel Clinic in Kathmandu.
How NIPT Screens for Down Syndrome
During pregnancy, small amounts of the baby's DNA — called cell-free fetal DNA — cross the placenta and enter the mother's bloodstream. By about 10 weeks of gestation, there is enough of this DNA in a maternal blood sample to analyse. The laboratory separates the fetal fraction and measures how much chromosome 21 material is present relative to other chromosomes.
In a typical pregnancy, about half of the cell-free DNA in maternal blood comes from the placenta. NIPT platforms measure this fetal fraction and require a minimum threshold — usually around 4 percent — to produce a reliable result. Very early testing, high maternal body mass index, or twin pregnancies can occasionally produce a "no-call" result that needs repeating.
The test is entirely safe for the pregnancy because it only requires a standard blood draw from the mother's arm — there is no needle near the baby and no risk of miscarriage, unlike diagnostic procedures such as amniocentesis.
- Requires only a maternal blood sample — no risk to the pregnancy.
- Available from approximately 10 weeks of gestation.
- Measures cell-free fetal DNA, primarily of placental origin.
- Screens chromosome 21 for trisomy 21 (Down syndrome).
- Also commonly reports trisomy 18 and 13 and sex chromosome conditions.
- Fetal fraction must be sufficient — usually above 4 percent — for a valid result.
Safe by Design
Because NIPT uses only maternal blood, it carries no miscarriage risk — unlike amniocentesis or CVS, which involve sampling around the baby.
High Accuracy
For trisomy 21, detection rates above 99 percent with false-positive rates under 1 percent make NIPT the most accurate screening option available.
Early Reassurance
Results are typically available within one to two weeks, giving families information early in pregnancy when decisions are less time-pressured.
Broader Screening
The same blood sample can screen for trisomy 18, trisomy 13 and sex chromosome conditions, and may report fetal sex where requested.
Who Should Consider NIPT for Down Syndrome
NIPT is available to all pregnant women regardless of age or risk factors. Traditionally, older maternal age was the main indication because Down syndrome risk rises with age — for example, the risk at age 40 is roughly ten times that at age 25. However, because most babies with Down syndrome are born to younger mothers simply because younger women have more babies overall, universal access is increasingly recommended.
Women with specific risk factors benefit particularly: those with a previous pregnancy affected by a chromosome condition, those with abnormal ultrasound findings or serum screening results, IVF pregnancies, twin pregnancies, and anyone with a family history suggesting a chromosomal condition.
Some women choose NIPT purely for reassurance after a worrying early pregnancy or ultrasound finding, even without formal risk factors. Because the test is safe and highly accurate, there is no harm in screening when anxiety is significant — provided results are interpreted with proper counselling.
- All pregnant women from ~10 weeks can access NIPT.
- Maternal age 35 or older is a common indication but not a requirement.
- Previous affected pregnancy or abnormal ultrasound finding.
- Abnormal first-trimester combined screening results.
- IVF, twin or higher-order multiple pregnancies.
- Family history of chromosomal conditions.
- Personal choice for reassurance — no risk factors required.
Universal Access
Down syndrome can occur in any pregnancy. NIPT is available to all women, not just those over 35 — and most affected babies are born to younger mothers.
After Concerning Findings
An abnormal ultrasound or high-risk serum screen makes NIPT particularly valuable as a next step before considering diagnostic testing.
IVF and Multiples
Women who conceived through IVF or carry twins often choose NIPT for its accuracy in situations where serum screening is less reliable.
Reassurance-Seeking
For women with significant anxiety about chromosome conditions, NIPT offers high-accuracy reassurance from a simple blood test.
Understanding NIPT Results for Down Syndrome
NIPT results for Down syndrome typically fall into categories: low-risk (screen negative), high-risk (screen positive), or no-call. A low-risk result means the chance of trisomy 21 is very low — it is reassuring but not a guarantee, because screening cannot detect every case and does not assess structural abnormalities or single-gene conditions.
A high-risk result means the test detected an excess of chromosome 21 material suggesting trisomy 21 is likely. This is not a diagnosis — the false-positive rate is low but real, which is why confirmatory diagnostic testing is essential before any decisions about the pregnancy.
No-call results occur when there is insufficient fetal DNA — usually from testing too early, high maternal weight, or technical factors. A repeat test after a week or two usually resolves this. Importantly, NIPT results should always be interpreted alongside ultrasound findings and in consultation with a clinician who can explain what the numbers mean for your specific situation.
- Low-risk result — trisomy 21 unlikely; routine antenatal care continues.
- High-risk result — increased likelihood; diagnostic confirmation needed.
- No-call — insufficient fetal fraction; repeat testing usually resolves.
- Screening cannot detect structural abnormalities or single-gene disorders.
- Residual risk remains even after a low-risk result.
- Results must be interpreted with ultrasound and clinical context.
Low-Risk Is Reassuring, Not Definitive
A low-risk NIPT greatly reduces the chance of Down syndrome but does not eliminate it — ultrasound and standard antenatal care continue as usual.
High-Risk Needs Confirmation
A high-risk result warrants amniocentesis or CVS for a definitive diagnosis — decisions should never be based on screening alone.
No-Call Happens
Insufficient fetal DNA is common with early testing or higher maternal weight — a repeat sample usually produces a valid result.
Context Is Everything
NIPT results are interpreted alongside ultrasound findings — a high-risk NIPT with a normal detailed scan still needs diagnostic confirmation.
What Happens After a High-Risk NIPT Result
A high-risk NIPT result for Down syndrome leads to genetic counselling and discussion of diagnostic options. The two confirmatory tests are amniocentesis — sampling amniotic fluid, usually after 15 weeks — and chorionic villus sampling (CVS) — sampling placental tissue, typically between 11 and 14 weeks. Both provide a definitive chromosomal diagnosis.
Diagnostic procedures carry a small miscarriage risk, which is why they are offered only after a high-risk screening result or other strong indication. This is the fundamental difference between screening and diagnosis: NIPT tells you the chance is high; amniocentesis or CVS tells you definitively whether trisomy 21 is present.
Whatever the outcome, support is essential. Families receiving a diagnosis of Down syndrome benefit from counselling about what the condition means, available supports in Nepal, and the full range of options. Our team provides non-directive counselling and connects families with appropriate resources and specialists.
- Genetic counselling follows any high-risk NIPT result.
- Amniocentesis — definitive diagnosis after ~15 weeks, small procedure risk.
- CVS — definitive diagnosis at 11–14 weeks, similar small risk.
- Diagnostic testing is never routine — only after high-risk screening.
- Non-directive counselling supports all decisions.
- Connections to Down syndrome support resources in Nepal.
Amniocentesis
A sample of amniotic fluid is tested for the baby's chromosomes — definitive diagnosis, typically after 15 weeks of pregnancy.
Chorionic Villus Sampling
Placental tissue sampling between 11–14 weeks provides earlier diagnosis than amniocentesis, with a similar small risk profile.
Small but Real Risk
Diagnostic procedures carry approximately a 0.5–1 percent miscarriage risk — this is why they are reserved for after high-risk screening.
Support Regardless of Outcome
Whether the diagnosis is confirmed or not, counselling and support services help families process information and make informed decisions.
NIPT Compared With Other Prenatal Screening
NIPT is not the only prenatal screening option. First-trimester combined screening — a blood test plus nuchal translucency ultrasound — has been the standard for decades and remains a valid option, particularly where NIPT is unavailable or unaffordable. Second-trimester quadruple screening is another serum-based option.
NIPT outperforms serum screening for trisomy 21 detection — higher detection rate and lower false-positive rate — which means fewer women need invasive diagnostic testing. However, NIPT does not assess structural abnormalities, which is why the 11–14 week ultrasound remains essential regardless of which biochemical screening is chosen.
In Nepal, where NIPT is available through private laboratories in Kathmandu, the practical choice often depends on cost, gestational age at booking, and personal preference. Some women combine NIPT with detailed ultrasound for the most comprehensive screening approach. Our clinicians help patients understand the trade-offs.
- First-trimester combined screening — standard, widely available, lower accuracy.
- NIPT — highest accuracy for trisomy 21, higher cost, from 10 weeks.
- Quadruple screening — second-trimester serum option.
- Ultrasound — essential for structural assessment regardless of screening choice.
- NIPT reduces but does not eliminate the need for diagnostic testing.
- Choice depends on cost, timing and personal preference.
vs. Combined Screening
NIPT detects more Down syndrome cases with fewer false alarms than first-trimester combined screening — but costs more.
Ultrasound Still Essential
No blood screening test replaces the 11–14 week ultrasound, which assesses physical structure that NIPT cannot see.
Cost vs. Accuracy
NIPT is the premium option for accuracy; combined screening is a valid lower-cost alternative where budget is a constraint.
Complementary, Not Exclusive
Many women choose NIPT for chromosomes plus detailed ultrasound for structure — together they provide the broadest screening.
NIPT and Related Services in Kathmandu
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| Obstetric/genetic counselling | Pre-test discussion of options, risks and what results mean. | Rs. 450–800 |
| NIPT — basic panel | Trisomy 21, 18, 13 screening from ~10 weeks. | Lab rate |
| NIPT — extended panel | Adds sex chromosome screening and microdeletions where available. | Lab rate |
| Dating / viability ultrasound | Confirms gestational age and viability before NIPT. | Rs. 1,500–3,000 |
| First-trimester combined screening | Blood test plus nuchal translucency ultrasound alternative. | Rs. 3,000–6,000 |
| Genetic counselling — post-result | Detailed discussion after high-risk or complex results. | Rs. 800–1,500 |
| Diagnostic referral | Amniocentesis or CVS coordination with specialist centre. | Per case |
| Follow-up antenatal care | Ongoing pregnancy monitoring after screening. | Per visit |
Indicative pricing. NIPT costs vary by laboratory platform and panel; confirm current rates when booking.
Why Families Choose Thamel Clinic for NIPT
- Accurate, validated testing — NIPT performed on established laboratory platforms with high detection rates for trisomy 21.
- Proper counselling first — pre-test discussion ensures you understand what NIPT can and cannot tell you before deciding.
- Clear result explanation — every result is explained by a clinician, not just a lab report, so you know what it means for your pregnancy.
- Honest about limits — we explain that NIPT is screening, not diagnosis, and outline confirmatory pathways clearly.
- Complete pathway — from initial consultation through screening, result discussion and diagnostic referral if needed.
- Confidential and respectful — genetic testing is sensitive; our counselling is private and culturally aware.
- Transparent pricing — costs quoted upfront with no hidden fees for result review or counselling.
- Connections to support — referrals to Down syndrome resources and specialist centres in Nepal when needed.
Frequently Asked Questions
How accurate is NIPT for Down syndrome?
NIPT is the most accurate prenatal screening test for trisomy 21, with detection rates above 99 percent and false-positive rates below 1 percent in most studies. However, it is screening — a high-risk result still needs diagnostic confirmation.
When can I have NIPT done?
NIPT is available from approximately 10 weeks of pregnancy, once there is enough cell-free fetal DNA in maternal blood. Earlier testing may produce a no-call result requiring a repeat sample.
Is NIPT safe for my baby?
Yes — completely. NIPT requires only a blood draw from your arm. There is no needle near the baby and no risk of miscarriage, unlike amniocentesis or CVS.
What does a high-risk NIPT result mean?
It means the test detected an excess of chromosome 21 material suggesting Down syndrome is more likely than average. It is not a diagnosis — amniocentesis or CVS is needed to confirm before any decisions.
What is the difference between NIPT and amniocentesis?
NIPT is a screening blood test that estimates the chance of a chromosome condition. Amniocentesis is a diagnostic procedure that samples amniotic fluid to give a definitive answer — it carries a small miscarriage risk.
Does NIPT tell me the baby's sex?
Many NIPT panels can report fetal sex because they analyse sex chromosomes, but this varies by laboratory and some regions restrict this information. Ask about panel options when booking.
Can NIPT detect all chromosome problems?
No. NIPT screens for common trisomies (21, 18, 13) and sometimes sex chromosome conditions and microdeletions. It cannot detect structural abnormalities, single-gene disorders, or every possible chromosome issue.
What if my NIPT result is "no-call"?
A no-call means there was insufficient fetal DNA for analysis — usually from testing too early, high maternal weight, or twins. A repeat test after one to two weeks usually produces a valid result.
How much does NIPT cost in Nepal?
NIPT is a private-pay service in Nepal, typically costing tens of thousands of rupees depending on the laboratory and panel. We provide transparent pricing before you commit.
Do I still need ultrasound if I have NIPT?
Yes — absolutely. NIPT screens chromosomes but cannot assess the baby's physical structure. The 11–14 week ultrasound and later anatomy scans remain essential regardless of NIPT results.
Is NIPT available outside Kathmandu?
NIPT is primarily available through private laboratories in Kathmandu. Patients from other regions may need to travel to the Valley or arrange sample transport through their healthcare provider.
What happens if Down syndrome is diagnosed?
You will receive genetic counselling about what the diagnosis means, information about available supports in Nepal, and the full range of options. Counselling is non-directive — the decision is always yours.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
NIPT Eligibility
Who should consider NIPT and when it can be performed.
NIPT Accuracy
How accurate NIPT is for Down syndrome and other conditions.
NIPT Procedure
Step-by-step guide to the NIPT blood test process.
Understanding NIPT Results
What different NIPT results mean for your pregnancy.
NIPT vs Quadruple Screening
Comparison of NIPT with traditional serum screening.
NIPT vs Diagnostic Testing
Screening versus diagnosis — amniocentesis and CVS explained.
NIPT for Edwards Syndrome
NIPT screening for trisomy 18.
NIPT for Patau Syndrome
NIPT screening for trisomy 13.
Prenatal Genetic Testing in Nepal
Complete guide to genetic testing options during pregnancy.
NIPT Test in Kathmandu
Where to get NIPT testing in Kathmandu, Nepal.
Related Health Guides
Medical Review & Sources
Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Role: Obstetric and genetic counselling reviewers, Thamel Clinic, Kathmandu
Last reviewed: 2026-11-08
Reviewed against current professional guidance on non-invasive prenatal testing. This is general medical information; a registered clinician must assess each patient before testing.
References
- Prenatal screening for Down syndrome — NHS, 2024
- Non-invasive prenatal testing information — American College of Obstetricians and Gynecologists, 2023
- Down syndrome fact sheet — World Health Organization, 2024
Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered